News | March 07, 2025
Medicamen Biotech partners with South African business conglomerate
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The company has withdrawn all litigation against Vikas Lifecare Limited post withdrawal of the Alwar Case by VLL
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
This approval is a significant achievement in expanding the availability of this critical therapeutic,
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Subscribe To Our Newsletter & Stay Updated
